Growth Metrics

OptimizeRx (OPRX) Short-term Investments (2022 - 2023)

OptimizeRx's Short-term Investments history spans 2 years, with the latest figure at $53.6 million for Q3 2023.

  • On a quarterly basis, Short-term Investments rose 43.11% to $53.6 million in Q3 2023 year-over-year; TTM through Sep 2023 was $53.6 million, a 43.11% increase, with the full-year FY2022 number at $55.9 million, changed N/A from a year prior.
  • Short-term Investments hit $53.6 million in Q3 2023 for OptimizeRx, up from $52.9 million in the prior quarter.
  • Over the last five years, Short-term Investments for OPRX hit a ceiling of $57.3 million in Q1 2023 and a floor of $37.5 million in Q3 2022.